Fagron NV (FAGR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 16.65%

Healthy long term growth as Net Sales has grown by an annual rate of 10.49%

Positive results in Jun 25

With ROE of 0.00%, it has a Fair valuation with a 3.02 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

EUR 1,536 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.55

Return on Equity

0.00%

Price to Book

3.06

Revenue and Profits:

Net Sales:

157 Million

(Quarterly Results - Dec 2012)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-0.72%

6 Months

-4.16%

1 Year

13.39%

2 Years

19.39%

3 Years

66.13%

4 Years

54.16%

5 Years

8.24%

Fagron NV for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

10.49%

EBIT Growth (5y)

9.64%

EBIT to Interest (avg)

5.07

Debt to EBITDA (avg)

1.75

Net Debt to Equity (avg)

0.47

Sales to Capital Employed (avg)

0.95

Tax Ratio

22.34%

Dividend Payout Ratio

22.18%

Pledged Shares

Institutional Holding

ROCE (avg)

16.65%

ROE (avg)

18.42%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.02

EV to EBIT

EV to EBITDA

EV to Capital Employed

2.30

EV to Sales

6.08

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'12 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2012 is 0.00% vs 0.00% in Dec 2011",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2012 is 0.00% vs 0.00% in Dec 2011",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'12",
        "Dec'11",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.29% vs 11.57% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.08% vs 1.28% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "872.00",
          "val2": "763.00",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.70",
          "val2": "140.00",
          "chgp": "19.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.70",
          "val2": "23.00",
          "chgp": "11.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.80",
          "val2": "-4.70",
          "chgp": "-2.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "81.00",
          "val2": "71.00",
          "chgp": "14.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.50%",
          "val2": "138.20%",
          "chgp": "1.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'12 - YoY

Dec'12

Dec'11

Change(%)

Net Sales

156.80

0.00

Operating Profit (PBDIT) excl Other Income

0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.00

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2012 is 0.00% vs 0.00% in Dec 2011

Consolidated Net Profit

YoY Growth in quarter ended Dec 2012 is 0.00% vs 0.00% in Dec 2011

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

872.00

763.00

14.29%

Operating Profit (PBDIT) excl Other Income

166.70

140.00

19.07%

Interest

25.70

23.00

11.74%

Exceptional Items

-4.80

-4.70

-2.13%

Consolidate Net Profit

81.00

71.00

14.08%

Operating Profit Margin (Excl OI)

149.50%

138.20%

1.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 14.29% vs 11.57% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 14.08% vs 1.28% in Dec 2023

All Annual Results

Company CV

About Fagron NV

Fagron NV

Retailing

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

Company Coordinates

Company Details

Venecoweg 20A , NAZARETH None : 9810

Tel: 32 80 012880

https://fagron.com/

Registrar Details